Van Biesen W, Vanholder R, Lameire N
Department of Internal Medicine, University Hospital, Gent, Belgium.
Adv Ren Replace Ther. 1998 Jul;5(3):218-31. doi: 10.1016/s1073-4449(98)70035-4.
Although glucose is still the most widely used osmotic agent for peritoneal dialysis, it has several disadvantages that challenge its long-term use. During the past years several nonglucose molecules have been tested as osmotic agents for peritoneal dialysis. Most of these molecules have some advantages over glucose, but they also have drawbacks. Every new agent should be carefully tested for performance and long-term safety. In the following review, alternative osmotic agents are discussed, including their potential indications and drawbacks. Major issues include the improvement of biocompatibility and preservation of peritoneal membrane integrity by using dialysate with more physiologic pH, the effect on nutritional status by using dialysate with amino acids, and maintenance of peritoneal ultrafiltration in the long-term by using dialysate with polyglucose. It is believed that in the near future, mixtures of osmotic agents will become most appropriate to obtain the best performance.
尽管葡萄糖仍是腹膜透析中使用最广泛的渗透剂,但它存在一些缺点,这对其长期使用构成了挑战。在过去几年中,几种非葡萄糖分子已被测试作为腹膜透析的渗透剂。这些分子大多比葡萄糖有一些优势,但也有缺点。每种新药剂都应仔细测试其性能和长期安全性。在以下综述中,将讨论替代渗透剂,包括它们的潜在适应症和缺点。主要问题包括通过使用具有更生理pH值的透析液来改善生物相容性和保持腹膜完整性,通过使用含氨基酸的透析液对营养状况的影响,以及通过使用含聚葡萄糖的透析液长期维持腹膜超滤。人们认为,在不久的将来,渗透剂混合物将最适合获得最佳性能。